Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape.
Bushman M, Kahn R, Taylor BP, Lipsitch M, Hanage WP.
Cell. 2021 12 22. 184(26):6229-6242.e18. PMID: 34910927
Bushman M, Kahn R, Taylor BP, Lipsitch M, Hanage WP.
Cell. 2021 12 22. 184(26):6229-6242.e18. PMID: 34910927
Bushman M, Worby C, Chang HH, Kraemer MUG, Hanage WP.
Eur J Epidemiol. 2021 Apr. 36(4):429-439. PMID: 33881667